The Patent Cooperation Treaty (PCT) Provides Positive Opinion on BYND Cannasoft’s AI-Based Female Treatment Device
ASHKELON, Israel and VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises Inc. (Nasdaq:BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today it has received a positive opinion from the Patent Cooperation Treaty (PCT) for its Artificial Intelligence (AI) Sex Tech-based Female Treatment Device. Along with its EZ-G device, the company plans to develop its groundbreaking AI-based adult device that incorporates machine learning algorithms based on user response to stimulation. The device will provide users with a personalized experience that meets various needs related to sexual pleasure, pain management, and medical conditions. BYND Cannasoft plans to move quickly toward monetizing any patents awarded to take advantage of the burgeoning trend in the global AI market, which is estimated to expand at a compound annual growth rate (CAGR) of 39.4 percent to reach USD 422.37 billion by 2028.i
Related news for (BCAN)
- 24/7 Market News Snapshot 15 May, 2024 – BYND Cannasoft Enterprises (NASDAQ: BCAN)
- BYND Cannasoft Entering Production Agreements for its EZ-G Device
- Aegis Capital Corp. Acted as Exclusive Placement Agent on a $1.5 Million Registered Direct Offering for BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN)
- Positive opinion from ISA-Israel patent office Provides the ability to file a patent application under the Patent Prosecution Highway (PPH) in the US
- Israel’s Finance Ministry Increases Israel Innovation Authority’s High-Tech Sector Fast-Track Fund to $100 Million During Wartime